PERITONEAL-MACROPHAGES FROM C57BL/6 MICE ORALLY IMMUNIZED WITH TOXOPLASMA-GONDII ANTIGENS IN ASSOCIATION WITH CHOLERA-TOXIN POSSESS AN ENHANCED ABILITY TO INHIBIT PARASITE MULTIPLICATION

被引:0
|
作者
BOURGUIN, I [1 ]
CHARDES, T [1 ]
BOUT, D [1 ]
机构
[1] UFR SCI PHARMACEUT,INSERM,CJF,F-37200 TOURS,FRANCE
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 1995年 / 12卷 / 02期
关键词
TOXOPLASMA GONDII; CHOLERA TOXIN; MACROPHAGE; GAMMA-INTERFERON;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gamma-interferon (IFN-gamma) has been reported robe a major mediator of resistance to toxoplasma infection, mainly through macrophage activation. Cholera toxin used as oral adjuvant induces enhanced protection. Following oral immunization of C57BL/6 mice with a Toxoplasma gondii sonicate (TSo), in association with either cholera toxin (CT) or its B subunit (CTB), the ability of primed sensitized peritoneal macrophages (PM phi) to prevent T. gondii intracellular proliferation in vitro was examined both with and without rIFN-gamma activation. Under these conditions, the inhibition of T. gondii multiplication was greatly enhanced in PM phi from mice immunized with a TSo and CT as an oral adjuvant. In contrast, PM phi from mice immunized with a TSo in association with CTB showed a decrease in their microbiostatic activity towards T. gondii. This negative effect on IFN-gamma-treated PM phi was cancelled out by the addition of a small amount of CT in association with TSo and CTB in the immunization regimen. These data suggest that CT could act as an oral adjuvant in vaccination against toxoplasmosis by increasing the microbiostatic activity of M phi activated with IFN-gamma. Further studies, using intestinal effector cells such as enterocytes, are needed to confirm the value of CT for enhancing this major mechanism of protection against T. gondii infection.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 6 条
  • [1] ORAL IMMUNIZATION WITH TOXOPLASMA-GONDII ANTIGENS IN ASSOCIATION WITH CHOLERA-TOXIN INDUCES ENHANCED PROTECTIVE AND CELL-MEDIATED-IMMUNITY IN C57BL/6 MICE
    BOURGUIN, I
    CHARDES, T
    BOUT, D
    INFECTION AND IMMUNITY, 1993, 61 (05) : 2082 - 2088
  • [2] C57BL/6 mice immunized with synthetic peptides from Toxoplasma gondii surface and microneme immunodominant antigens are able to decrease parasite burden in the brain tissues
    Silva Barros, Heber Leao
    Santana, Silas Silva
    Arantes Marquez Pajuaba, Ana Claudia
    Cardoso Barros, Patricio da Silva
    de Carvalho, Fernando dos Reis
    de Paiva, Vinicius Fernandes
    Patriarca Mineo, Tiago Wilson
    Mineo, Jose Roberto
    ACTA TROPICA, 2019, 196 : 1 - 6
  • [3] SUSCEPTIBILITY OF PERITONEAL-MACROPHAGES FROM RESISTANT (C57L/J) AND SUSCEPTIBLE (C57BL/6J) MICE TO INFECTION INVITRO BY LEISHMANIA-DONOVANI
    TANNER, CE
    HAIBON, PR
    JOURNAL OF LEUKOCYTE BIOLOGY, 1984, 36 (03) : 398 - 398
  • [4] AGE-RELATED-CHANGES IN THE METABOLISM OF ACETYLATED LOW-DENSITY LIPOPROTEINS BY PERITONEAL-MACROPHAGES FROM C57BL/6CRSCL MICE
    ARAKI, A
    ITO, H
    URANO, S
    IIYAMA, M
    SHIMADA, Y
    JOURNALS OF GERONTOLOGY, 1994, 49 (03): : B104 - B109
  • [5] Recombinant SAG2A Protein from Toxoplasma gondii Modulates Immune Profile and Induces Metabolic Changes Associated with Reduced Tachyzoite Infection in Peritoneal Exudate Cells from Susceptible C57BL/6 Mice
    dos Santos, Thaise Anne Rocha
    de Oliveira, Mario Cezar
    de Andrade Silva, Edson Mario
    dos Santos, Uener Ribeiro
    Ferreira, Monaliza Macedo
    Soares, Ana Luisa Correa
    Silva, Neide Maria
    de Oliveira Mendes, Tiago Antonio
    Leal-Sena, Jamilly Azevedo
    da Cunha-Junior, Jair Pereira
    Mineo, Tiago Wilson Patriarca
    Mineo, Jose Roberto
    Mendes, erica Araujo
    Lima-Santos, Jane
    Pirovani, Carlos Priminho
    MICROORGANISMS, 2024, 12 (11)
  • [6] COMPARATIVE EFFECTS OF ENDRIN ON HEPATIC LIPID-PEROXIDATION AND DNA-DAMAGE, AND NITRIC-OXIDE PRODUCTION BY PERITONEAL-MACROPHAGES FROM C57BL/6J AND DBA/2 MICE
    BAGCHI, M
    HASSOUN, E
    AKUBUE, P
    BAGCHI, D
    STOHS, SJ
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1993, 105 (03): : 525 - 529